[1]
A. F. da Silva, F. R. V. Marques, J. C. Freitas, and J. G. B. Rivera, “PHARMACOTHERAPEUTIC FOLLOW-UP OF PATIENTS WHO USE TENOFOVIR DISOPROXIL FUMARATE IN PRE-EXPOSURE TO HIV”, REASE, vol. 9, no. 7, pp. 351–363, Aug. 2023.